1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Next Generation Sequencing: new trials by email Literature Review of Next Generation Sequencing trials Research Report on Next Generation Sequencing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma Evomela, Next Generation Sequencing, Prochlorperazine - Multiple Myeloma | Early Phase 1 | Withdrawn | Koen van Besien | 2023-09-01 | 2024-04-02 |
Multiple Myeloma (1)
Koen van Besien (1)
United States (1)